
Sign up to save your podcasts
Or


Equities saw mixed performance this week, with AI mega caps hitting record valuations, despite broader market weakness and a cautious outlook from the Federal Reserve.
Stock Highlights
Insurance Sector: Suncorp (SUN) and Insurance Australia Group (IAG) experienced significant developments. Suncorp's sale of its banking arm to ANZ Group was seen as a positive move, enabling it to focus on general insurance. IAG announced major new reinsurance partnerships, marking a significant transaction for the company.
Collins Foods (CKF): Reported a 0.8% decline in same-store sales for May and June. Interim CEO Kevin Perkins expects challenging conditions to persist into 2025 due to higher mortgage rates, rents, energy bills, and inflation.
Bannerman Energy (BNM): Launched a $76 million share placement to support its Etango project in Namibia. This move aims to capitalize on the rising demand for uranium amid a global shift towards nuclear energy and interest in decarbonizing power grids.
ResMed (RMD): Shares plunged over 13% after Eli Lilly's weight-loss drug tirzepatide showed significant reductions in obstructive sleep apnoea severity, renewing concerns about the impact on ResMed's market.
Trade of the Week
By MPC MarketsEquities saw mixed performance this week, with AI mega caps hitting record valuations, despite broader market weakness and a cautious outlook from the Federal Reserve.
Stock Highlights
Insurance Sector: Suncorp (SUN) and Insurance Australia Group (IAG) experienced significant developments. Suncorp's sale of its banking arm to ANZ Group was seen as a positive move, enabling it to focus on general insurance. IAG announced major new reinsurance partnerships, marking a significant transaction for the company.
Collins Foods (CKF): Reported a 0.8% decline in same-store sales for May and June. Interim CEO Kevin Perkins expects challenging conditions to persist into 2025 due to higher mortgage rates, rents, energy bills, and inflation.
Bannerman Energy (BNM): Launched a $76 million share placement to support its Etango project in Namibia. This move aims to capitalize on the rising demand for uranium amid a global shift towards nuclear energy and interest in decarbonizing power grids.
ResMed (RMD): Shares plunged over 13% after Eli Lilly's weight-loss drug tirzepatide showed significant reductions in obstructive sleep apnoea severity, renewing concerns about the impact on ResMed's market.
Trade of the Week